Poly Medicure Ltd (POLYMED) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Poly Medicure Ltd reported sales of ₹525 Cr, operating profit of ₹125 Cr (OPM 24%) and net profit of ₹85 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
POLYMED quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 420 424 441 403 444 494 535 525 Expenses 305 310 321 298 329 382 424 400 Operating Profit 115 114 119 106 115 111 110 125 OPM 27% 27% 27% 26% 26% 23% 21% 24% Other Income 27 24 27 43 35 21 19 35 Interest 3 3 2 3 3 6 6 6 Depreciation 21 21 21 23 25 29 38 36 Profit before tax 118 113 123 123 122 98 85 117 Tax 26% 25% 25% 24% 25% 27% 24% 27% Net Profit 87 85 92 93 92 71 65 85 EPS in Rs 8.63 8.41 9.06 9.19 9.06 7 6.54 8.49
POLYMED profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 922 1,115 1,375 1,669 1,875 1,997 Expenses 707 847 1,014 1,213 1,429 1,536 Operating Profit 215 267 361 456 446 461 OPM 23% 24% 26% 27% 24% 23% Other Income 40 38 60 94 119 110 Interest 6 11 14 14 21 22 Depreciation 54 57 63 83 116 128 Profit before tax 195 237 344 453 427 422 Tax 25% 25% 25% 25% 25% - Net Profit 147 179 258 339 321 313 EPS in Rs 15.28 18.69 26.91 33.41 31.78 31.09 Dividend Payout 16% 16% 11% 10% 11% -
POLYMED balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 48 48 51 51 51 Reserves 1,194 1,422 2,715 2,868 3,055 Borrowings 149 174 180 240 354 Other Liabilities 187 215 246 429 401 Total Liabilities 1,577 1,859 3,192 3,587 3,861 Fixed Assets 635 867 1,084 1,439 1,694 CWIP 78 76 101 83 99 Investments 126 167 1,076 930 755 Other Assets 738 748 930 1,135 1,313 Total Assets 1,577 1,859 3,192 3,587 3,861
POLYMED cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 123 191 266 233 246 Cash from Investing Activity -85 -179 -241 -1,187 -224 Cash from Financing Activity -35 -13 -20 951 20 Net Cash Flow 3 -1 5 -3 43 Free Cash Flow -31 -48 -9 -97 -59 CFO/OP 80% 93% 94% 71% 78%
POLYMED ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 82 77 72 76 103 Inventory Days 218 237 205 233 323 Days Payable 115 105 89 70 91 Cash Conversion Cycle 185 209 188 239 335 Working Capital Days 81 69 54 75 105 ROCE 17% 18% 24% 18% 12%